{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:19:18Z","timestamp":1787505558061,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.msard.2025.106286","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T06:23:03Z","timestamp":1737526983000},"page":"106286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A real-world data of serum neurofilament light chain in a large cohort of Egyptian multiple sclerosis patients: Hospital-based study"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5679-9833","authenticated-orcid":false,"given":"Eman M.","family":"khedr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Nasreldein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein Bahey","family":"El-Deen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A","family":"El-Mokhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa M.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.msard.2025.106286_bib0001","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jamaneurol.2023.3997","article-title":"Neurofilament light chain elevation and disability progression in multiple sclerosis","volume":"80","author":"Abdelhak","year":"2023","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106286_bib0002","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000885","article-title":"Serum neurofilament light chain: no clear relation to cognition and neuropsychiatric symptoms in stable MS","author":"Aktas O","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.msard.2025.106286_bib0003","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/nmt-2021-0058","article-title":"Updates and advances in multiple sclerosis neurotherapeutics","volume":"13","author":"Amin","year":"2023","journal-title":"Neurodegener. Dis. Manage"},{"key":"10.1016\/j.msard.2025.106286_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103617","article-title":"Neurofilament light chains: a reliable biomarker of disease activity in MS","volume":"59","author":"Ashfaq","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2025.106286_bib0005","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1212\/NXI.0000000000000102","article-title":"Early CNS neurodegeneration in radiologically isolated syndrome","volume":"2","author":"Azevedo","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2025.106286_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.837452","article-title":"Diffusion tensor imaging revealed microstructural changes in normal-appearing white matter regions in relapsing\u2013Remitting multiple sclerosis","volume":"16","author":"Bao","year":"2022","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.msard.2025.106286_bib0007","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40120-022-00427-8","article-title":"Serum neurofilament light trajectories and their relation to subclinical radiological disease activity in relapsing multiple sclerosis patients in the APLIOS trial","volume":"12","author":"Bar-Or","year":"2022","journal-title":"Neurol. Ther."},{"issue":"7","key":"10.1016\/j.msard.2025.106286_bib0008","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3390\/jpm14070692","article-title":"Real-world study of serum neurofilament light chain levels in Ocrelizumab-treated people with relapsing multiple sclerosis","volume":"14","author":"Barrero Hern\u00e1ndez","year":"2024","journal-title":"J. Pers. Med."},{"issue":"8","key":"10.1016\/j.msard.2025.106286_bib0009","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/brain\/awy154","article-title":"Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis","volume":"141","author":"Barro","year":"2018","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.msard.2025.106286_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3988\/jcn.2022.0340","article-title":"Normative values for serum neurofilament light chain in US adults","volume":"20","author":"Beltran","year":"2024","journal-title":"J. Clin. Neurol."},{"issue":"11\u201312","key":"10.1016\/j.msard.2025.106286_bib0011","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1177\/13524585231195851","article-title":"Abnormal functional connectivity in radiologically isolated syndrome: a resting-state fMRI study","volume":"29","author":"Benito-Le\u00f3n","year":"2023","journal-title":"Multiple Sclerosis J."},{"issue":"10","key":"10.1016\/j.msard.2025.106286_bib0012","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1177\/1352458518782005","article-title":"Neurofilaments and 10-year follow-up in multiple sclerosis","volume":"24","author":"Bhan","year":"2018","journal-title":"Multiple Sclerosis J."},{"issue":"10","key":"10.1016\/j.msard.2025.106286_bib0013","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1093\/brain\/awab241","article-title":"The potential of serum neurofilament as biomarker for multiple sclerosis","volume":"144","author":"Bittner","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.msard.2025.106286_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102807","article-title":"Clinical implications of serum neurofilament in newly diagnosed MS patients: a longitudinal multicentre cohort study","volume":"56","author":"Bittner","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.msard.2025.106286_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jamaneurol.2019.3238","article-title":"Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis","volume":"77","author":"Bjornevik","year":"2020","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106286_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102666","article-title":"Variations in consecutive serum neurofilament light levels in healthy controls and multiple sclerosis patients","volume":"47","author":"Bridel","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.msard.2025.106286_bib0017","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1177\/13524585221097296","article-title":"Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis","volume":"28","author":"Brune","year":"2022","journal-title":"Multiple Sclerosis J."},{"issue":"11","key":"10.1016\/j.msard.2025.106286_bib0018","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamaneurol.2019.2137","article-title":"Association between serum neurofilament light chain levels and long-term disease course among patients with multiple sclerosis followed up for 12 years","volume":"76","author":"Cant\u00f3","year":"2019","journal-title":"JAMa Neurol."},{"issue":"11","key":"10.1016\/j.msard.2025.106286_bib0019","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamaneurol.2019.2137","article-title":"Association between serum neurofilament light chain levels and long-term disease course among patients with multiple sclerosis followed up for 12 years","volume":"76","author":"Cant\u00f3","year":"2019","journal-title":"JAMa Neurol."},{"issue":"6","key":"10.1016\/j.msard.2025.106286_bib0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2025.106286_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.642384","article-title":"The evolution of neurofilament light chain in multiple sclerosis","volume":"15","author":"Ferreira-Atuesta","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.msard.2025.106286_bib0022","first-page":"438","article-title":"Identifying progression in multiple sclerosis: new perspectives","author":"Filippi","year":"2020","journal-title":"John Wiley and Sons Inc."},{"key":"10.1016\/j.msard.2025.106286_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104970","article-title":"Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management","volume":"101","author":"Freedman","year":"2024","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.msard.2025.106286_bib0024","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/brain\/awaa098","article-title":"Neurofilaments: neurobiological foundations for biomarker applications","volume":"143","author":"Gafson","year":"2020","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.msard.2025.106286_bib0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/WCO.0000000000000561","article-title":"Disease-modifying treatments for early and advanced multiple sclerosis: a new treatment paradigm","volume":"31","author":"Giovannoni","year":"2018","journal-title":"Curr. Opin. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106286_bib0026","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.msard.2015.04.006","article-title":"Is it time to target no evident disease activity (NEDA) in multiple sclerosis?","volume":"4","author":"Giovannoni","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2025.106286_bib0027","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12974-018-1249-7","article-title":"Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis","volume":"15","author":"H\u00e5kansson","year":"2018","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.msard.2025.106286_bib0028","unstructured":"Hern\u00e1ndez, F.J.B., Villarubia, A.R., Fern\u00e1ndez, C.M., Martinez, V.G., Moral, A., Barrios-L\u00f3pez, J.M., Rivas, M.V.S., Mu\u00f1oz, A., Morales, R.P., 2024. Real-world study of serum neurofilament light chain levels in Ocrelizumab-treated people with relapsing multiple sclerosis."},{"issue":"15_supplement","key":"10.1016\/j.msard.2025.106286_bib0029","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.92.15_supplement.S12.008","article-title":"Natalizumab reduces serum concentrations of neurofilament light chain in secondary progressive Multiple sclerosis patients from the phase 3 ASCEND study (S12.008)","volume":"92","author":"Kapoor","year":"2019","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2025.106286_bib0030","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","article-title":"Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials","volume":"77","author":"Kappos","year":"2020","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2025.106286_bib0031","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.90.15_supplement.S8.006","article-title":"Siponimod reduces neurofilament light chain blood levels in secondary progressive multiple sclerosis patients (S8.006)","author":"Kuhle","year":"2018","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.msard.2025.106286_bib0032","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106286_bib0033","doi-asserted-by":"crossref","DOI":"10.1177\/17562864241239101","article-title":"Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a post hoc analysis","volume":"17","author":"Kuhle","year":"2024","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"9","key":"10.1016\/j.msard.2025.106286_bib0034","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/brain\/awac016","article-title":"How patients with multiple sclerosis acquire disability","volume":"145","author":"Lublin","year":"2022","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.msard.2025.106286_bib0036","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/joim.13215","article-title":"Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis","volume":"289","author":"Piehl","year":"2021","journal-title":"J. Intern. Med."},{"issue":"6","key":"10.1016\/j.msard.2025.106286_bib0037","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/acn3.51060","article-title":"Temporal association of sNfL and gad-enhancing lesions in multiple sclerosis","volume":"7","author":"Rosso","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"17_supplement_2","key":"10.1016\/j.msard.2025.106286_bib0038","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1212\/WNL.0000000000203936","article-title":"Serum neurofilament light chain association with progression independent of activity in people with early RRMS (S9.005)","volume":"100","author":"Satyanarayan","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2025.106286_bib0039","doi-asserted-by":"crossref","DOI":"10.1002\/ana.27034","article-title":"Smouldering-associated worsening in multiple sclerosis: an international consensus statement on definition, biology, clinical implications, and future directions","author":"Scalfari","year":"2024","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106286_bib0041","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200055","article-title":"Serum neurofilament identifies patients with multiple sclerosis with severe focal axonal damage in a 6-year longitudinal cohort","volume":"10","author":"Steffen","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.msard.2025.106286_bib0042","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67504-6","article-title":"Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis","volume":"10","author":"Thebault","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2025.106286_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.654942","article-title":"Serum neurofilament light chain measurement in MS: hurdles to clinical translation","volume":"15","author":"Thebault","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.msard.2025.106286_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103535","article-title":"High or increasing serum NfL is predictive of impending multiple sclerosis relapses","volume":"59","author":"Thebault","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106286_bib0046","series-title":"Diagnosis of Multiple sclerosis: 2017 Revisions of the McDonald Criteria","first-page":"162","author":"Thompson","year":"2018"},{"key":"10.1016\/j.msard.2025.106286_bib0047","doi-asserted-by":"crossref","unstructured":"Visva, S., Oliveria, J.P., 2019. Multiple Sclerosis: unraveling the neuropathology and mechanisms of neurodegeneration. 16(1), 72\u201390 doi:10.15173\/MUMJ.V16I1.2035.","DOI":"10.15173\/mumj.v16i1.2035"},{"issue":"9","key":"10.1016\/j.msard.2025.106286_bib0048","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1007\/s00415-020-09917-x","article-title":"Neurofilaments in progressive multiple sclerosis: a systematic review","volume":"268","author":"Williams","year":"2020","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106286_bib0049","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1474-4422(22)00469-0","article-title":"Time to reconsider the classification of multiple sclerosis","volume":"22","author":"Yamamura","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106286_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.689938","article-title":"Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies","volume":"15","author":"Yuan","year":"2021","journal-title":"Front. Neurosci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825000306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T21:04:34Z","timestamp":1739480674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825000306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":47,"alternative-id":["S2211034825000306"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106286","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A real-world data of serum neurofilament light chain in a large cohort of Egyptian multiple sclerosis patients: Hospital-based study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106286"}}